National Research Corp logo

National Research Corp share price today

(NRC)

National Research Corp share price is $19.5 & ₹1,651.30 as on 10 Dec 2024, 2.30 'hrs' IST

$19.5

▲

0.51

(2.69%)

Market is closed - opens 8 PM, 10 Dec 2024

View live National Research Corp share price in Dollar and Rupees. Guide to invest in National Research Corp from India. Also see the sentimental analysis on Indian investors investing in National Research Corp. Get details on the Indian mutual funds that are investing in National Research Corp. Get Analyst recommendations and forecasts along with all the National Research Corp's financials.

National Research Corp share price movements

  • $18.88
    $19.71

    Day's Volatility :4.21%

  • $17.62
    $42.18

    52 Weeks Volatility :58.23%

National Research Corp Returns

PeriodNational Research CorpSector (Health Care)Index (Russel 2000)
3 Months
-11.14%
-6.4%
0.0%
6 Months
-25.38%
-0.9%
0.0%
1 Year
-53.72%
9.9%
0.0%
3 Years
-54.81%
8.2%
-20.3%

National Research Corp Key Statistics

in dollars & INR

Previous Close
$18.99
Open
$18.88
Today's High
$19.71
Today's Low
$18.88
Market Capitalization
$451.4M
Today's Volume
$83.8K
52 Week High
$42.18
52 Week Low
$17.62
Revenue TTM
$144.2M
EBITDA
$43.3M
Earnings Per Share (EPS)
$1.12
PE Ratio
17.17
Dividend Yield
2.43%
Profit Margin
18.79%
Quarterly Earnings Growth YOY
-0.25%
Return On Equity TTM
58.56%

How to invest in National Research Corp from India?

It is very easy for Indian residents to invest directly in National Research Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the National Research Corp stock in both rupees (INR) and dollars (USD). Search for National Research Corp or NRC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of National Research Corp or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of National Research Corp shares which would translate to 0.043 fractional shares of National Research Corp as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards National Research Corp

10%

Period: Sep 10, 2024 to Dec 9, 2024. Change in 30 Days versus previous period

Search volume for National Research Corp on INDmoney from India has grown in the last 30 days as on Dec 10, 2024. 10% more investors are searching National Research Corp in the last 30 days versus the previous period.

Global Institutional Holdings in National Research Corp

  • Kayne Anderson Rudnick Investment Management LLC

    13.03%

  • BlackRock Inc

    4.62%

  • Vanguard Group Inc

    4.20%

  • Morgan Stanley - Brokerage Accounts

    3.91%

  • Dimensional Fund Advisors, Inc.

    2.52%

  • Geode Capital Management, LLC

    1.79%

Analyst Recommendation on National Research Corp

Sell

    0%Buy

    37%Hold

    62%Sell

Based on 8 Wall street analysts offering stock ratings for National Research Corp(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
5
5
5

Insights on National Research Corp

  • Price Movement

    In the last 6 months, NRC stock has moved down by -25.1%

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 35.02M → 35.81M (in $), with an average increase of 2.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 8.85M → 5.68M (in $), with an average decrease of 13.0% per quarter

  • NRC vs DOCS (1 yr)

    In the last 1 year, Doximity, Inc. has given 125.7% return, outperforming this stock by 179.4%

  • NRC vs HQY (3 yr)

    In the last 3 years, National Research Corp has experienced a drawdown of -54.0%, however Healthequity Inc resisted the overall trend and outperformed by 50.2%

  • Price to Sales

    ForNRC every $1 of sales, investors are willing to pay $3.2, whereas for Doximity, Inc., the investors are paying $20.0 for every $1 of sales.

National Research Corp Financials in INR & Dollars

FY18Y/Y Change
Revenue
$119.7M
↑ 1.81%
Net Income
$30.0M
↑ 30.96%
Net Profit Margin
25.1%
↑ 5.58%
FY19Y/Y Change
Revenue
$128.0M
↑ 6.93%
Net Income
$32.4M
↑ 7.85%
Net Profit Margin
25.32%
↑ 0.22%
FY20Y/Y Change
Revenue
$133.3M
↑ 4.14%
Net Income
$37.3M
↑ 14.98%
Net Profit Margin
27.96%
↑ 2.64%
FY21Y/Y Change
Revenue
$148.0M
↑ 11.01%
Net Income
$37.5M
↑ 0.55%
Net Profit Margin
25.32%
↓ 2.64%
FY22Y/Y Change
Revenue
$151.6M
↑ 2.44%
Net Income
$31.8M
↓ 15.12%
Net Profit Margin
20.98%
↓ 4.34%
FY23Y/Y Change
Revenue
$148.6M
↓ 1.97%
Net Income
$31.0M
↓ 2.61%
Net Profit Margin
20.84%
↓ 0.14%
Q2 FY23Q/Q Change
Revenue
$36.2M
↓ 0.86%
Net Income
$7.3M
↑ 4.44%
Net Profit Margin
20.11%
↑ 1.02%
Q3 FY23Q/Q Change
Revenue
$37.9M
↑ 4.93%
Net Income
$7.9M
↑ 8.29%
Net Profit Margin
20.76%
↑ 0.65%
Q4 FY23Q/Q Change
Revenue
$38.0M
↑ 0.15%
Net Income
$8.9M
↑ 12.47%
Net Profit Margin
23.31%
↑ 2.55%
Q1 FY24Q/Q Change
Revenue
$35.3M
↓ 7.07%
Net Income
$6.4M
↓ 28.21%
Net Profit Margin
18.01%
↓ 5.3%
Q2 FY24Q/Q Change
Revenue
$35.0M
↓ 0.83%
Net Income
$6.2M
↓ 2.89%
Net Profit Margin
17.63%
↓ 0.38%
Q3 FY24Q/Q Change
Revenue
$35.8M
↑ 2.28%
Net Income
$5.7M
↓ 7.89%
Net Profit Margin
15.88%
↓ 1.75%
FY18Y/Y Change
Total Assets
$107.7M
↓ 15.42%
Total Liabilities
$88.6M
↑ 137.7%
FY19Y/Y Change
Total Assets
$110.7M
↑ 2.79%
Total Liabilities
$77.8M
↓ 12.2%
FY20Y/Y Change
Total Assets
$133.4M
↑ 20.54%
Total Liabilities
$69.1M
↓ 11.16%
FY21Y/Y Change
Total Assets
$157.5M
↑ 18.08%
Total Liabilities
$72.2M
↑ 4.48%
FY22Y/Y Change
Total Assets
$130.5M
↓ 17.19%
Total Liabilities
$58.4M
↓ 19.08%
FY23Y/Y Change
Total Assets
$122.4M
↓ 6.15%
Total Liabilities
$73.5M
↑ 25.77%
Q2 FY23Q/Q Change
Total Assets
$133.6M
↓ 0.51%
Total Liabilities
$55.9M
↓ 6.31%
Q3 FY23Q/Q Change
Total Assets
$120.1M
↓ 10.1%
Total Liabilities
$62.3M
↑ 11.43%
Q4 FY23Q/Q Change
Total Assets
$122.4M
↑ 1.92%
Total Liabilities
$73.5M
↑ 18.02%
Q1 FY24Q/Q Change
Total Assets
$120.9M
↓ 1.25%
Total Liabilities
$84.0M
↑ 14.27%
Q2 FY24Q/Q Change
Total Assets
$119.1M
↓ 1.5%
Total Liabilities
$78.9M
↓ 6.03%
Q3 FY24Q/Q Change
Total Assets
$131.8M
↑ 10.66%
Total Liabilities
$97.2M
↑ 23.16%
FY18Y/Y Change
Operating Cash Flow
$39.8M
↑ 41.85%
Investing Cash Flow
$-6.0M
↓ 2.4%
Financing Cash Flow
$-54.5M
↑ 158.08%
FY19Y/Y Change
Operating Cash Flow
$40.9M
↑ 2.68%
Investing Cash Flow
$-4.7M
↓ 22.02%
Financing Cash Flow
$-36.3M
↓ 33.31%
FY20Y/Y Change
Operating Cash Flow
$40.6M
↓ 0.69%
Investing Cash Flow
$-3.7M
↓ 20.02%
Financing Cash Flow
$-15.5M
↓ 57.35%
FY21Y/Y Change
Operating Cash Flow
$46.3M
↑ 14.05%
Investing Cash Flow
$-8.5M
↑ 128.63%
Financing Cash Flow
$-18.2M
↑ 17.15%
FY22Y/Y Change
Operating Cash Flow
$36.3M
↓ 21.75%
Investing Cash Flow
$-9.8M
↑ 15.52%
Financing Cash Flow
$-55.6M
↑ 206.04%
Q2 FY23Q/Q Change
Operating Cash Flow
$8.8M
↑ 13.96%
Investing Cash Flow
$-4.3M
↑ 35.64%
Financing Cash Flow
$-5.7M
↓ 2.25%

National Research Corp Technicals Summary

Sell

Neutral

Buy

National Research Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

National Research Corp Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
National Research Corp
National Research Corp
-9.68%
-25.38%
-53.72%
-54.81%
-69.93%
Solventum Corp
Solventum Corp
-2.74%
23.05%
0.68%
0.68%
0.68%
Doximity, Inc.
Doximity, Inc.
-9.68%
85.2%
130.21%
-0.65%
4.38%
Veeva Systems Inc.
Veeva Systems Inc.
-2.2%
23.22%
32.77%
-13.18%
62.4%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-4.48%
9.13%
14.67%
34.84%
34.84%
Healthequity Inc
Healthequity Inc
0.57%
16.03%
42.32%
145.01%
40.84%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
National Research Corp
National Research Corp
17.17
17.17
NA
0.0
0.59
0.19
0.02
1.48
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
62.3
62.3
2.42
0.9
0.19
0.12
NA
5.15
Veeva Systems Inc.
Veeva Systems Inc.
63.3
63.3
1.37
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
22.74
22.74
8.96
4.28
0.22
0.06
0.0
18.2
Healthequity Inc
Healthequity Inc
84.43
84.43
1.1
2.19
0.05
0.03
NA
24.7
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
National Research Corp
National Research Corp
Sell
$451.4M
-69.93%
17.17
18.79%
Solventum Corp
Solventum Corp
Hold
$10.8B
0.68%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$10.1B
4.38%
62.3
33.69%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$38.5B
62.4%
63.3
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$37.9B
34.84%
22.74
8.56%
Healthequity Inc
Healthequity Inc
Buy
$9.0B
40.84%
84.43
9.61%

About National Research Corp

nrc health (nasdaq:nrcia and nrcib) has helped healthcare organizations illuminate and improve the moments that matter to patients, residents, physicians, nurses, and staff for 35 years. our empathetic heritage, proprietary methods, and holistic approach enable our partners to better understand the people they care for, and in turn, design experiences that inspire loyalty and trust. for more information call 800-388-4264, write to info@nrchealth.com, or visit www.nrchealth.com.
Organization
National Research Corp
Employees
435
CEO
Mr. Michael D. Hays
Industry
Health Services

Management People of National Research Corp

NameTitle
Mr. Michael D. Hays
Founder, CEO, President & Director
Ms. Helen L. Hrdy
Chief Operating Officer
Mr. Christophe Louvion
Chief Product & Technology Officer
Mr. Andy Monnich
Chief Corporate Development Officer
Mr. Jon Boumstein
Chief Delivery Officer
Mr. Jason Hahn
Chief Revenue Officer
Ms. Vinitha Ramnathan
Chief Product Officer
Ms. Jennifer Baron
Chief Experience Officer
Ms. Linda Stacy
Secretary
Megan Charko
Senior Manager of Content Marketing

Important FAQs about investing in National Research Corp from India :

What is National Research Corp share price today?

National Research Corp (NRC) share price today is $19.50.

Can Indians buy National Research Corp shares?

Yes, Indians can invest in the National Research Corp (NRC) from India.

With INDmoney, you can buy National Research Corp at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy National Research Corp at zero transaction cost.

How can I buy National Research Corp shares from India?

It is very easy to buy National Research Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of National Research Corp be purchased?

Yes, you can buy fractional shares of National Research Corp with INDmoney app.

What are the documents required to start investing in National Research Corp stocks?

To start investing in National Research Corp, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of National Research Corp

Today’s highest price of National Research Corp (NRC) is $19.71.

Today’s lowest price of National Research Corp (NRC) is $18.88.

What is today's market capitalisation of National Research Corp

Today's market capitalisation of National Research Corp NRC is 451.4M

What is the 52 Week High and Low Range of National Research Corp

  • 52 Week High

    $42.18

  • 52 Week Low

    $17.62

How much percentage National Research Corp is down from its 52 Week High?

National Research Corp (NRC) share price is $19.50. It is down by 53.77% from its 52 Week High price of $42.18.

How much percentage National Research Corp is up from its 52 Week low?

National Research Corp (NRC) share price is $19.50. It is up by 10.67% from its 52 Week Low price of $17.62.

What are the historical returns of National Research Corp?

  • 1 Month Returns

    -9.68%

  • 3 Months Returns

    -25.38%

  • 1 Year Returns

    -53.72%

  • 5 Years Returns

    -69.93%

Who is the Chief Executive Officer (CEO) of National Research Corp

Mr. Michael D. Hays is the current Chief Executive Officer (CEO) of National Research Corp.